Valuation: Tofflon Science and Technology Group Co., Ltd.

Market Cap 11.76B 1.75B 1.53B 1.44B 1.31B 2.46B 168B 2.47B 17.3B 6.68B 85.57B 6.59B 6.44B 275B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 8.04B 1.2B 1.05B 988M 897M 1.68B 115B 1.69B 11.84B 4.57B 58.55B 4.51B 4.41B 188B EV / Sales 2026 *
1.46x
EV / Sales 2027 * 1.74x
Free-Float
25.51%
Yield 2026 *
0.84%
Yield 2027 * 1.42%
29/08 Tofflon Science and Technology Group Co., Ltd. Proposes Interim Cash Dividend on A Shares for the First Half of 2026, Payable on 10 September 2026 CI
28/08 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
26/05 Tofflon Science and Technology Group Co., Ltd. Announces 2025 Final Profit Distribution Plan on A Shares, Payable on June 1, 2026 CI
28/04 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
28/04 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
29/10/25 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
17/09/25 Tofflon Science and Technology Group Co., Ltd. Approves Interim Cash Dividend on A Shares for the Year 2025, Payable on September 25, 2025 CI
29/08/25 Tofflon Science and Technology Group Co., Ltd. Proposes Interim Cash Dividend for the Year 2025 CI
27/08/25 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
13/06/25 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component A Share Index CI
13/06/25 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component Index CI
22/05/25 Tofflon Science and Technology Group Co., Ltd. Approves Cash Dividend on Share A for 2024 CI
26/04/25 Tofflon Science and Technology Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024 CI
1 day+7.59%
1 week+20.23%
Current month+3.07%
1 month+12.94%
3 months+36.36%
6 months-4.33%
Current year-1.59%
1 week 12.76
Extreme 12.76
15.49
1 month 12.75
Extreme 12.75
15.88
Current year 10.42
Extreme 10.42
20.37
1 year 10.42
Extreme 10.42
20.37
3 years 9.6
Extreme 9.6
20.37
5 years 9.6
Extreme 9.6
57.5
10 years 5.16
Extreme 5.16
68
Manager TitleAgeSince
Chief Executive Officer 62 01/01/1993
Director of Finance/CFO 45 01/07/2012
Corporate Officer/Principal 57 01/01/2001
Director TitleAgeSince
Chairman 62 01/03/2008
Director/Board Member 54 30/03/2008
Director/Board Member 53 30/03/2008
Date Insider Type Main position Quantity % Market Cap. Importance
5/2/24 Buy

Chief Executive Officer

40,000 0.0072%
1/2/24 Buy

Chief Executive Officer

30,000 0.0054%
17/1/24 Buy

Chief Executive Officer

80,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
+7.59%+20.23%+6.11%-18.90% 1.75B
+1.97%-0.70%+24.86%+138.35% 119B
+1.00%+2.04%+36.99%+44.07% 34.79B
-0.08%+1.10%+26.50%+69.17% 29.91B
-1.13%-1.51%-11.90%+8.19% 27.87B
-0.30%-2.68%+43.57%-5.69% 26.57B
-0.96%-0.86%+8.46%+30.58% 25.24B
-0.04%+0.56%-24.35%+12.65% 25.11B
+2.43%+4.76%+390.10%+1,995.80% 25.57B
-1.83%-0.44%+25.79%+46.76% 22.87B
Average +0.86%+1.50%+52.61%+232.10% 33.86B
Weighted average by Cap. +0.70%+0.20%+47.37%+216.44%

Financials

2026 *2027 *
Net sales 5.53B 825M 719M 679M 616M 1.16B 79.12B 1.16B 8.13B 3.14B 40.22B 3.1B 3.03B 129B 5.99B 893M 779M 735M 668M 1.25B 85.69B 1.26B 8.81B 3.4B 43.57B 3.35B 3.28B 140B
Net income - -
Net Debt -3.71B -554M -483M -456M -414M -776M -53.15B -779M -5.46B -2.11B -27.02B -2.08B -2.03B -86.95B -1.36B -202M -177M -167M -151M -284M -19.42B -285M -2B -770M -9.88B -760M -744M -31.78B
Logo Tofflon Science and Technology Group Co., Ltd.
Tofflon Science and Technology Group Co Ltd is a China-based company mainly engaged in the research, development, production, and sales of pharmaceutical equipment, and the provision of technical services. The Company mainly operates four businesses. The bioprocessing business mainly provides equipment, instruments, and consumables such as fermentation systems, precision packaging systems, and traditional Chinese medicine extraction systems. The pharmaceutical preparations business mainly provides equipment and instruments required for the preparation of injectable dosage forms, oral solid dosage forms, and the inspection and packaging of finished drugs. The integrated engineering solutions business mainly provides information system software and intelligent manufacturing integrated solutions. The food engineering business is mainly engaged in the manufacturing of equipment for the liquid food sector, and the provision of system solutions, process engineering, and overall solutions.
Employees
5,479
Date Price Change Volume
18/09/26 CNY 15.45 +7.59% 33,153,276
17/09/26 CNY 14.36 +4.13% 24,307,976
16/09/26 CNY 13.79 +0.29% 6,943,995
15/09/26 CNY 13.75 -1.01% 9,097,217
14/09/26 CNY 13.89 +8.09% 18,358,383
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
15.45CNY
Average target price
16.50CNY
Spread / Average Target
+6.80%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300171 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!